Biotech Firm HilleVax Prices US$200 Million IPO
Biopharmaceutical company HilleVax, Inc. (Nasdaq: HLVX) began trading on the Nasdaq Global Select Market on Friday. The firm’s initial public
Read moreBiopharmaceutical company HilleVax, Inc. (Nasdaq: HLVX) began trading on the Nasdaq Global Select Market on Friday. The firm’s initial public
Read more